Navigation Links
Cancer patients to be treated by qualified professionals
Date:12/3/2007

The European Society for Medical Oncology (ESMO) is calling on European politicians to voice their support for a decisive step to help ensure cancer patients receive the best possible treatment.

At a meeting of the European Commission today representatives from all EU Member States met in Brussels to consider the status of medical oncology as a recognized specialty under EU law.

Such recognition is an essential step in providing optimal treatment to the millions of Europeans who have cancer or who develop cancer every year, says Dr. Jose Baselga, ESMO President-Elect. It would enable the free movement of medical oncologists within EU Member States, with their professional qualifications being automatically recognized.

A determining factor for optimal cancer treatment and research is the level of training, knowledge and skills of oncology professionals, says Dr. Baselga.

Medical oncologists are doctors who specialize in taking care of cancer patients. They have training in internal medicine, and subsequent specialization in the comprehensive management of patients with malignancies.

Medical oncologists are trained in the scientific basis of cancer treatment, prevention, screening, and diagnosis. Hospitals in every European country, and around the world, employ medical oncologists to help treat their patients.

Medical oncology is recognized as a specialty in most of the EU Member States, the United States and many other countries around the world, says Dr. Adamos Adamou, co-chair of the European Members of Parliament Against Cancer (MAC). We believe it is time the EU joined them.

Working in multidisciplinary teams with surgeons and radiation oncologists, medical oncologists are responsible for the systemic treatment of cancer patients with chemotherapy, hormonal therapy, immune and targeted therapies, as well as supportive care. Medical oncologists also engage in clinical cancer research in the form of clinical trials.

Currently, however, the specialty of medical oncology is not formally recognized by the European Union. Discussions within the EU have been ongoing for some time in a continuing and concerted effort on the part of medical professionals from across the continent to achieve that recognition.

We urge patients and politicians to voice their support for the recognition of medical oncology as a specialty, and to agree on minimum training periods, says Pascale Blaes, Director of the ESMO Brussels office.

Oncologists and cancer patients across the EU will be watching the outcome closely, because of the growing urgency to keep cancer as a high priority on the EU healthcare agenda, Pascale Blaes says.


'/>"/>

Contact: Gracemarie Bricalli
media@esmo.org
0041-919-731-911
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination Drug ... p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination products ... increased attention from all stakeholders in the development of new chemical entities. , ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Leadership Series at Zuckerberg San Francisco General Hospital on April 5-7. The series ... behaviors and create new habits. The workshops cover a broad range of topics, ...
(Date:2/12/2016)... , ... February 12, 2016 , ... The Jones Agency, ... communities across eastern Texas, is launching a cooperative charity drive with the Tarrant Area ... Serving more than 50,000 individuals and families in need, the Tarrant County Food Bank ...
(Date:2/12/2016)... ... ... Miami Dental Specialists is excited to bring patients the choice of ceramic, ... Dental Specialists will offer the non-metal implants as a safe, holistic and hygienic approach ... the dental implant manufacturer, Straumann, to bring this cutting-edge technology to Miami. ...
(Date:2/12/2016)... ... 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased ... upcoming Feb. 24 webinar that will discuss ways health plans and PBMs are ... the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat cholesterol. ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Calif. , Feb. 12, 2016  Sequent Medical, ... in a study to evaluate the safety and effectiveness ... the treatment of ruptured intracranial aneurysms.  Prof Laurent ... Hospital, in Paris, France and ... patient. France and Germany.  ...
(Date:2/12/2016)... Ontario , Feb. 12, 2016  Aralez Pharmaceuticals ... pharmaceutical company, today announced the Company will ring the Nasdaq ... New York at 4:00 p.m. ... formation of Aralez. Adrian Adams , ... be held 3:50 to 4:00 p.m. ET.  A live ...
(Date:2/12/2016)... Ungarn, February 12, 2016 ... sich auf den ungedeckten medizinischen Bedarf bei ... Ergebnisse seines klinischen Forschungsprogramms bekannt. Das Programm, ... ergab Verbesserungen ihrer respiratorischen Funktionen und anderer ... , ein Medizintechnikunternehmen, das sich auf den ...
Breaking Medicine Technology: